Nov
03
03
FDA Approves First Oral Drug To Reduce MS Relapses
Posted @ 03-Nov-10 16:05 under MS, MS News, News by pmbTags: approves, Drug, First, Oral, Reduce, relapses
The U.S. Food and Drug Administration has approved Gilenya capsules (fingolimod) to reduce relapses and delay disability progression in patients with relapsing forms of multiple sclerosis (MS)…
Multiple Sclerosis News From Medical News Today
Related posts:
- FDA extends priority review of oral MS drug Cladribine
- Novartis Receives European Commission Approval For Gilenya(R), The First Oral Multiple Sclerosis Treatment For Use In The EU
- Oral Multiple Sclerosis Drugs Heat Up
- Five Year Follow-Up Data Show Alemtuzumab Achieves Sustained Reduction In Relapses And Disability In Multiple Sclerosis
- RebiDose™ – the first pre-filled pen to deliver MS drug launched in UK
ADD COMMENTS
